{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:58Z","timestamp":1792457038266,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mpa.0b013e31824abdc0","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T08:15:57Z","timestamp":1337674557000},"page":"1029-1038","source":"Crossref","is-referenced-by-count":39,"title":["Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer"],"prefix":"10.1097","volume":"41","author":[{"given":"Wenbo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":". The patterns and dynamics of genomic instability in metastatic pancreatic cancer.","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"R2-7-20210212","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","article-title":"Advanced pancreatic carcinoma: current treatment and future challenges.","volume":"7","author":"Stathis","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1517\/13543784.15.11.1395","article-title":"Pancreatic cancer: a review of recent advances.","volume":"15","author":"Eckel","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"R4-7-20210212","first-page":"353","article-title":"Gemcitabine. New first-line therapy for pancreatic cancer.","volume":"4","author":"King","year":"1996","journal-title":"Cancer Pract"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"3rd, Moore MJ, Andersen J, et al.. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R6-7-20210212","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MPA.0b013e3181c0decc","article-title":". Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.","volume":"39","author":"Ina","year":"2010","journal-title":"Pancreas"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ctrv.2008.11.007","article-title":". Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.","volume":"35","author":"Rivera","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"R8-7-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000055290","article-title":"Gemcitabine: progress in the treatment of pancreatic cancer.","volume":"60","author":"Heinemann","year":"2001","journal-title":"Oncology"},{"key":"R9-7-20210212","first-page":"19","article-title":"Small heat shock proteinsrole in apoptosis, cancerogenesis and diseases associated with protein aggregation in Polish.","volume":"53","author":"Laskowska","year":"2007","journal-title":"Postepy Biochem"},{"key":"R10-7-20210212","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1432-1033.1996.0653p.x","article-title":". Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27.","volume":"237","author":"Garrido","year":"1996","journal-title":"Eur J Biochem"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00432-008-0460-9","article-title":". Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line.","volume":"135","author":"Yang","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"R12-7-20210212","first-page":"1603","article-title":". Expression of the heat shock protein HSP27 in human ovarian cancer.","volume":"1","author":"Langdon","year":"1995","journal-title":"Clin Cancer Res"},{"key":"R13-7-20210212","first-page":"6174","article-title":". Blockade of Hsp27 overcomes bortezomibproteasome inhibitor PS-341 resistance in lymphoma cells.","volume":"63","author":"Chauhan","year":"2003","journal-title":"Cancer Res"},{"key":"R14-7-20210212","first-page":"7099","article-title":". Heat shock protein expression independently predicts clinical outcome in prostate cancer.","volume":"60","author":"Cornford","year":"2000","journal-title":"Cancer Res"},{"key":"R15-7-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/10428190109064582","article-title":"Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.","volume":"42","author":"Chen","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R16-7-20210212","first-page":"2666","article-title":". Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.","volume":"8","author":"Kiviharju","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R17-7-20210212","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.bbrc.2005.08.247","article-title":"Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.","volume":"336","author":"Miyata","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-7-20210212","first-page":"65","article-title":". Triptolide inhibits the growth and metastasis of solid tumors.","volume":"2","author":"Yang","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"R19-7-20210212","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.exphem.2008.08.002","article-title":". Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.","volume":"36","author":"Pigneux","year":"2008","journal-title":"Exp Hematol"},{"key":"R20-7-20210212","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1074\/jbc.M009713200","article-title":". Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.","volume":"276","author":"Chang","year":"2001","journal-title":"J Biol Chem"},{"key":"R21-7-20210212","first-page":"855","article-title":". PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.","volume":"2","author":"Fidler","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"R22-7-20210212","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1074\/jbc.M512044200","article-title":". Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death.","volume":"281","author":"Westerheide","year":"2006","journal-title":"J Biol Chem"},{"key":"R23-7-20210212","doi-asserted-by":"crossref","first-page":"13443","DOI":"10.1074\/jbc.274.19.13443","article-title":". Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-boxnuclear factor of activated T-cells and NF-kappaB transcriptional activation.","volume":"274","author":"Qiu","year":"1999","journal-title":"J Biol Chem"},{"key":"R24-7-20210212","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1349-7006.2007.00506.x","article-title":". K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.","volume":"98","author":"Rejiba","year":"2007","journal-title":"Cancer Sci"},{"key":"R25-7-20210212","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1021\/jm900960v","article-title":". Novel triazole ribonucleoside down-regulates heat shock protein 27 and induces potent anticancer activity on drug-resistant pancreatic cancer.","volume":"52","author":"Xia","year":"2009","journal-title":"J Med Chem"},{"key":"R26-7-20210212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2005.10.001","article-title":". Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.","volume":"241","author":"Wan","year":"2006","journal-title":"Cancer Lett"},{"key":"R27-7-20210212","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2005-09-3898","article-title":". Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.","volume":"108","author":"Carter","year":"2006","journal-title":"Blood"},{"key":"R28-7-20210212","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.2001.5427","article-title":". Heat shock proteins: endogenous modulators of apoptotic cell death.","volume":"286","author":"Garrido","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R29-7-20210212","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":". Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"R30-7-20210212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2217\/14796694.4.1.41","article-title":"The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.","volume":"4","author":"Boeck","year":"2008","journal-title":"Future Oncol"},{"key":"R32-7-20210212","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1038\/sj.onc.1204981","article-title":". Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.","volume":"20","author":"Jiang","year":"2001","journal-title":"Oncogene"},{"key":"R33-7-20210212","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1078-0432.CCR-08-2141","article-title":". Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.","volume":"15","author":"Shi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R34-7-20210212","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1074\/jbc.274.19.13451","article-title":". PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells.","volume":"274","author":"Lee","year":"1999","journal-title":"J Biol Chem"},{"key":"R35-7-20210212","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2007-05-091504","article-title":". Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.","volume":"111","author":"Carter","year":"2008","journal-title":"Blood"},{"key":"R36-7-20210212","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/emm.2002.64","article-title":". Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.","volume":"34","author":"Lee","year":"2002","journal-title":"Exp Mol Med"},{"key":"R37-7-20210212","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11605-009-1065-6","article-title":". TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells.","volume":"14","author":"Borja-Cacho","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R38-7-20210212","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/onc.2008.89","article-title":". Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.","volume":"27","author":"Matsui","year":"2008","journal-title":"Oncogene"},{"key":"R39-7-20210212","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1158\/0008-5472.CAN-07-1077","article-title":". Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.","volume":"67","author":"Phillips","year":"2007","journal-title":"Cancer Res"},{"key":"R40-7-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4143\/crt.2008.40.1.22","article-title":". Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.","volume":"40","author":"Choi","year":"2008","journal-title":"Cancer Res Treat"},{"key":"R41-7-20210212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1681\/ASN.2006070727","article-title":". Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.","volume":"18","author":"He","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R42-7-20210212","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3835(01)00532-8","article-title":". Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.","volume":"168","author":"Yamamoto","year":"2001","journal-title":"Cancer Lett"},{"key":"R43-7-20210212","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1158\/1078-0432.CCR-06-2090","article-title":"Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.","volume":"13","author":"Zhang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R44-7-20210212","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00018-008-7458-y","article-title":"New insights into the mechanism of heat shock response activation.","volume":"65","author":"Shamovsky","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R45-7-20210212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1379\/CSC-14R.1","article-title":"On mechanisms that control heat shock transcription factor activity in metazoan cells.","volume":"9","author":"Voellmy","year":"2004","journal-title":"Cell Stress Chaperones"},{"key":"R46-7-20210212","first-page":"105","article-title":"Stress-induced activation of the heat-shock response: cell and molecular biology of heat-shock factors.","volume":"64","author":"Cotto","year":"1999","journal-title":"Biochem Soc Symp"},{"key":"R47-7-20210212","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1535-7163.MCT-08-0157","article-title":". Cisplatin abrogates the geldanamycin-induced heat shock response.","volume":"7","author":"McCollum","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"R48-7-20210212","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/bjc.1994.140","article-title":"A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer.","volume":"69","author":"Love","year":"1994","journal-title":"Br J Cancer"},{"key":"R49-7-20210212","first-page":"1345","article-title":". Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.","volume":"31","author":"Mori-Iwamoto","year":"2007","journal-title":"Int J Oncol"},{"key":"R50-7-20210212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000321019","article-title":". KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.","volume":"57","author":"Taba","year":"2010","journal-title":"Chemotherapy"},{"key":"R51-7-20210212","first-page":"2661","article-title":". HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.","volume":"57","author":"Garrido","year":"1997","journal-title":"Cancer Res"},{"key":"R52-7-20210212","doi-asserted-by":"crossref","first-page":"24173","DOI":"10.1074\/jbc.273.37.24173","article-title":". A role for the p38 mitogen-activated protein kinaseHsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini.","volume":"273","author":"Schafer","year":"1998","journal-title":"J Biol Chem"},{"key":"R53-7-20210212","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/35023595","article-title":". Hsp27 negatively regulates cell death by interacting with cytochrome c.","volume":"2","author":"Bruey","year":"2000","journal-title":"Nat Cell Biol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006676-201210000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:13:04Z","timestamp":1618035184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201210000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e31824abdc0","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}